Skip navigation

Evaluate the Impact of Potential Changes for Pharmacies and PBMs

June 13-14, 2019
  • Washington, DC

At CBI’s DIR Fees Forum 2019 you'll gain insight into the legislative and regulatory changes to DIR Fees and how it affects pharmacies and PBMs. Pharmacies, health plans and PBMs come together to discuss the proposed DIR reform and how to develop better processes for more transparency and consistency. This important conference discusses strategies to improve pharmacy operations and financial performance, as well as tools pharmacies can implement now to help estimate/accrue financial impact in an unbiased format.

COMPELLING CONFERENCE TOPICS:

  • Update from Capitol Hill on Policies Affecting DIR Fees
  • Panel Discussion Addressing How Stakeholders are Preparing for the Newly Proposed Regulations
  • Gain Insight into the Pharmacy Quality Alliance Methodology
  • Get the PBM Perspective on the Road to Transparency

MULTI-STAKEHOLDER PERSPECTIVES FROM:

Vanderbilt University Medical Center King & Spalding BluePeak Advisors
AscellaHealth LLC URx U.S. House of Representatives
Pharmacy Quality Alliance Pharmacy Quality Solutions
The Pew Charitable Trusts National Community Pharmacists Association
Appro-RX Managed Health Care Associates, Inc. Milliman

DIR Fees Forum 2019

Evaluate the Impact of Potential Changes for Pharmacies and PBMs

At CBI’s DIR Fees Forum 2019 you'll gain insight into the legislative and regulatory changes to DIR Fees and how it affects pharmacies and PBMs. Pharmacies, health plans and PBMs come together to discuss the proposed DIR reform and how to develop better processes for more transparency and consistency. This important conference discusses strategies to improve pharmacy operations and financial performance, as well as tools pharmacies can implement now to help estimate/accrue financial impact in an unbiased format.

COMPELLING CONFERENCE TOPICS:

  • Update from Capitol Hill on Policies Affecting DIR Fees
  • Panel Discussion Addressing How Stakeholders are Preparing for the Newly Proposed Regulations
  • Gain Insight into the Pharmacy Quality Alliance Methodology
  • Get the PBM Perspective on the Road to Transparency

MULTI-STAKEHOLDER PERSPECTIVES FROM:

Vanderbilt University Medical Center King & Spalding BluePeak Advisors
AscellaHealth LLC URx U.S. House of Representatives
Pharmacy Quality Alliance Pharmacy Quality Solutions
The Pew Charitable Trusts National Community Pharmacists Association
Appro-RX Managed Health Care Associates, Inc. Milliman